Marketresearchnews

Friday, 9 April 2021

Global and North America Organic and Natural Feminine Care Market: Drivers, Restraints, Opportunities, and Threats (2020-2027)

Organic and natural feminine hygiene products, also known as menstrual products, are derived from organic cotton. The biodegradable nature of these products makes it appealing to women who use it to treat sensitive skin and tissues in the vaginal area.

The global and North America organic and natural feminine care market is poised to reach a value of USD 3,990.93 million by 2023, as per the latest findings of Market Research Future (MRFR). The inclination of women towards organically derived products is likely to propel the market to exhibit 7.06% CAGR over the forecast period (2018-2023). Organic products can reduce the probability of acquiring cancer and other chronic diseases.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7441

Initiatives by nations to create awareness and negate the taboo of menstruation is likely to induce massive demand for organic and natural feminine care products. In May 2018, the government of India launched an affordable pad under a special scheme to make it available for women in rural areas. But shortage of organic and natural feminine care products in supermarkets can act as a growth deterrent in the market.

Segmentation Overview

The global and North America organic and natural feminine care market is segmented on the basis of product and distribution channel. Products include sanitary pads, panty liners & shields, and tampons. Major distribution channels considered for the sale of these products include supermarkets & hypermarkets, retail pharmacies, and online purchase.

Regional Overview

Based on regions, the global and North America organic and natural feminine care market is segmented into North America, South America, Europe, Asia Pacific (APAC), and the Middle East & Africa (MEA). North America is projected to lead the market till 2023 thanks to high awareness of feminine care among women. In addition, easy availability at retail and online channels can also be a factor fueling the market growth. APAC is expected to exhibit a robust CAGR over the forecast period owing to high scope for organic feminine care products in India, China, and South Korea. The high retention capacity of these products is primarily driving the demand in the region.

Competitive Landscape

Prominent players in the global and North America organic and natural feminine care market report include Procter & Gamble (U.S.), Armada & Lady Anion (Australia), Bodywise Limited (U.K.), Corman USA Inc. (U.S.), GladRags (U.S.), Heyday Care LLP (India), Maxim Hygiene (U.S.), Apropos (U.S.), Purganics (India), Rael (U.S.), Saathi (India), The Honest Company Inc. (U.S.), Tosama (Slovenia), and Veeda USA (U.S.).

The market is characterized by novel product launches and collaborations. This is exemplified by the rebranding of the Organyc line of products by Corman in 2017. It collaborated with reputed e-tailers such as CVS Pharmacy and Amazon in order to make its products available to a large audience simultaneously.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/organic-natural-feminine-care-market-7441

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Veterinary Infusion Pumps Market – Qualitative Insights by 2027

Market Scenario

Global veterinary infusion pumps market is expected to grow significantly over the forecast period. It is anticipated that the market held value of USD 85.9 million in 2017 and is projected to grow at a CAGR of 4.9% over the forecast period.

The factors such as growing demand for pet insurance and increasing animal healthcare expenditure, rising demand for animal-derived food products, and growth in the number of veterinary practitioners and their income levels are expected to propel the growth of the market. However, increasing animal care costs hamper the market growth over the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7417

Segmentation

The global veterinary infusion pumps market has been segmented into type, end user, and region.

Based on type, veterinary infusion pumps market is segmented into syringe infusion pump and large-volume infusion pump. The large-volume infusion pump segment is expected to account for the largest share segment of the market in 2017.

Based on end user, veterinary infusion pumps market is segmented into veterinary hospitals, veterinary clinics, and others. The veterinary hospitals segment is expected to account for the largest share segment of the market in 2017.

The veterinary infusion pumps market segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The veterinary infusion pumps market in the Americas further segmented into North America and Latin America, with the North American market divided into the US and Canada.

The European veterinary infusion pumps market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The veterinary infusion pumps market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.

The veterinary infusion pumps market in the Middle East & Africa segmented into the Middle East and Africa.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global veterinary infusion pumps market owing to a well-established player, growing demand for pet insurance and increasing animal healthcare expenditure, rising demand for animal-derived food products, and growth in the number of veterinary practitioners and their income level.

Europe is expected to hold the second largest position in the global veterinary infusion pumps market. The market growth in this region is attributed to growing adoption of companion animals and increasing prevalence of animal diseases.

The veterinary infusion pumps market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and Rest of Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region.

The Middle East & Africa has the least share of the veterinary infusion pumps market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/veterinary-infusion-pumps-market-7417

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Impact of Existing and Emerging Global Dental Lasers Market Trends And Forecast 2020-2027

Market Scenario

The global Dental Lasers Market is estimated reach USD 2.3 billion by 2023 with a CAGR of 5.2% during the forecast period (2017-2023).

The term “LASER” stands for ‘Light Amplification by the Stimulated Emission of Radiation’. Lasers emit a thin and concentrated beam of light, producing a thermal output. This thermal output has been used in the dentistry for endodontic treatment, oral surgery, implantology, peri-implantitis, periodontics, and others.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7375

From the past few years, the dental laser market has expanded with a steady CAGR. Factors such as, increasing prevalence of dental diseases, rising dental healthcare expenditure, growing R&D by the major market players, and increasing dental tourism are estimated to drive the market during the forecast period. Dental caries is a common chronic tooth tissue disease and effects ~90% of the world population (once in the lifetime). In the presence of such high prevalence of dental caries, demand of related therapeutics has increased. It is reportable that dental caries can be removed effectively by the application of dental lasers. Fast procedure and minimal invasion are some of the advantages associated with caries removal by dental lasers.

However, factors such as high cost of dental laser, changing reimbursement policies, lack of skilled work-force and awareness in the developing economies restraints the market growth. A sophisticated laser system is estimated to cost about USD 300, 000 to USD 500,000 or more.

Segmentation

The global dental lasers market is segmented based on product, application, and end users.

The dental lasers market, by product is segmented into soft tissue dental lasers and all tissue dental lasers. The soft tissue dental lasers is sub-segmented into diode lasers systems, CO2 laser systems, and Nd:YAG laser systems. The all tissue dental lasers segment is divided into Er:YAG laser systems, and Er,Cr:YSGG laser systems.

By application, the market is segmented into endodontic treatment, oral surgery, implantology, peri-implantitis, periodontics, and others.

The dental lasers market, by end user is segmented into hospitals & clinics, ambulatory surgical units, academic & research organizations.

Based on region, the global dental lasers market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas is sub-segmented into North America and Latin America. The North American region is further segmented into the US and Canada. The European region is divided into two, namely, Western Europe and Eastern Europe. Western Europe is further classified into Germany, Italy, France, the UK, Spain, and the rest of Western Europe. The Asia-Pacific region is sub-segmented into Japan, China, India, Australia, the Republic of Korea, and the rest of Asia-Pacific. The Middle Eastern and African region is sub-segmented into the United Arab Emirates, Saudi Arabia, Oman, Kuwait, Qatar, and the rest of the Middle East and Africa.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/dental-lasers-market-7375

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Veterinary Laboratory Testing Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

Global veterinary laboratory testing market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 2200 million in 2017 and is projected to grow at a CAGR of 10.1% over the forecast period.

The veterinary laboratory tests are usually performed to determine the cause of animal’s disorder.

Rising incidence of zoonotic diseases is one of the key factors driving the veterinary laboratory testing market. According to the Maine Center for Disease Control & Prevention, around 75% of emerging infectious diseases affecting humans are diseases of animal origin. The most commonly occurring zoonotic diseases are Rabies, Ebola Virus Disease, Q fever, and others. Various other factors such as rising awareness about animal diseases, technological advancements in veterinary testing, increasing expenditure on pet insurance and favourable funding policies are also expected to propel the growth of the market.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7326

However, high cost of veterinary testing and complications associated with the tests can hinder the market growth over the forecast period.

Segmentation

The global veterinary laboratory testing market has been segmented into animal type, technology, product, and end user.

The market, on the basis of animal type, has been segmented into companion animal and livestock animal. The companion animal segment is further classified as dogs, cats, horses and others. The livestock animal segment is further classified as cattle, pigs, poultry and others.

The market, by technology, has been segmented into clinical biochemistry, immunodiagnostics, hematology, molecular diagnostics, urinalysis, and others.

The clinical biochemistry segment is further classified as clinical chemistry analysis, glucose monitoring, and blood gas & electrolyte analysis. The clinical chemistry analysis segment includes clinical chemistry reagent clips and cartridges and clinical chemistry analyzers. The glucose monitoring segment includes blood glucose strips, glucose monitors and urine glucose strips. The blood gas & electrolyte analysis segment includes blood gas and electrolyte reagent clips and cartridges and blood gas & electrolyte analyzers.

The immunodiagnostics segment is further classified as ELISA tests, lateral flow assays, allergen-specific immunodiagnostic tests, immunoassay analyzers, and others. The lateral flow assays segment includes lateral flow rapid tests, and lateral flow strip readers.

The hematology segment is further classified as hematology cartridges, and hematology analyzers.

The molecular diagnostics segment is further classified as polymerase chain reaction (PCR) tests, microarrays, and others.

The urinalysis segment is further classified as urinalysis clips & cartridges/panels, urine analyzers, and urine test strips.

The market, by product, has been segmented into consumables and instruments.

The market, by end user, has been segmented into veterinary hospitals & clinics, in-house testing, research institutes, diagnostic laboratories, and others. The veterinary hospitals & clinics segment held the largest segment of the market in 2017. This can be attributed to the increasing incidence of zoonotic diseases. On the other hand, the academic institutes segment is estimated to be the fastest growing segment.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The veterinary laboratory testing market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European veterinary laboratory testing market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The veterinary laboratory testing market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The veterinary laboratory testing market in the Middle East & Africa has been segmented into the Middle East and Africa.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/veterinary-laboratory-testing-market-7326

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Sleep Testing Services Market – Qualitative Insights by 2027

Market Scenario

Global sleep testing services market is expected to grow significantly over the forecast period. It is anticipated that the market held a valuation of USD 5.9 billion in 2017 and is projected to grow at a CAGR of 13.2% over the forecast period. Sleep testing services are a set of medical tests that are used to recognize and diagnose sleeping disorders. They record breathing patterns, oxygen levels in blood, leg & eye movements, brainwaves and heart rate.

The factors such as increasing prevalence of sleep disorders, private insurance service providers and heavy adoption of the services by people are expected to propel the growth of the market. However, the high cost associated with sleep testing services can hamper the market growth over the forecast period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/7275

Segmentation

The Global sleep testing services market has been segmented into diagnostic services, treatment monitoring services and end user.

The market, on the basis of diagnostic services, has been segmented into home sleep testing and in-lab sleep testing. In-lab sleep testing is further segmented into electroencephalogram, full polysomnography, CPAP/BiPAP titration, multiple sleep latency test (MSLT) and maintenance of wakefulness test (MWT).

The market, by treatment monitoring services, has been segmented into obstructive sleep apnea, insomnia, restless legs syndrome, circadian rhythm disorders, narcolepsy and rapid eye movement (REM) sleep disorder. The obstructive sleep apnea segment is expected to hold the largest market share owing to large number of people suffering from the disorder. Insomnia is expected to be the fastest growing segment owing to the growing prevalence of the disorder.

The market, by end users, has been segmented into hospitals, sleep centers, home care settings and others.

The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The sleep testing services market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European sleep testing services market has been segmented into Western Europe and Eastern Europe. Western Europe has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The sleep testing services market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The sleep testing services market in the Middle East & Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the global sleep testing services market owing to rising prevalence of sleep disorders in the region and rising popularity of the services by American people. According to a data published by the American Academy of Sleep Medicine in September 2014, 25 million adults in the US suffer from obstructive sleep apnea. Europe is expected to hold the second largest position in the global sleep testing services market. The market growth in this region is attributed to the rising awareness of sleep testing services. The sleep testing services market in Asia-Pacific region consists of countries namely China, Japan, Republic of Korea, India, Australia and the Rest of the Asia-Pacific. The Asia-Pacific region is expected to be fastest growing region owing to the growing prevalence of sleep disorders. According to a report published by the Public Library of Science (PLOS) in February 2017, 15% people in China suffer from insomnia. The Middle East & Africa are expected to hold the least share of the market. The market growth in this region is expected to be driven by a developing healthcare infrastructure.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/sleep-testing-services-market-7275

About US:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Wednesday, 7 April 2021

Global Microtome Market 2020 Business Insights & Deep Analysis To 2027 By World’s Top 10 Key Players

Market Highlights

Microtome Market accounted for USD 120 Million in 2018 at a CAGR of 6.1%.

Market Synopsis

A microtome is a tool used to cut extremely thin sections of tissue samples of plants or animals. Microtomes help in extremely fine cuts that are important for preparations used in microscopy. The high preference of microtome in cancer biopsy will drive the growth positively over the forecast period due to rising cases of cancer worldwide. According to WHO, around 18.1 million new cases of cancer were diagnosed in 2018.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/8568

The growth of the global microtome market is driven by various factors such as an increase in the incidence of chronic disorders, increasing prevalence of lifestyle diseases, and increasing mergers & acquisitions by prominent players in the market. However, lack of skilled workforce is projected to hamper the growth of the global microtome market.

The global microtome market is currently dominated by several market players such as Danaher Corporation, Thermo Fisher Scientific, and Sakura Finetek, among others. Additionally, growing growth strategies adopted by market players are driving the growth of the market. For instance, in 2018, Sakura Finetek launched Accu-Cut SRM 300 LT, manual microtome.

Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas is expected to be the largest market owing to the rising per capita healthcare expenditure. The microtome market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European microtome market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The microtome market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing prevalence of chronic disorders and increasing patient pool, the market in Asia-Pacific is expected to be the fastest-growing. The microtome market in the Middle East & Africa has been bifurcated into the Middle East and Africa.

Segmentation

The Global Microtome Market has been segmented based on product, application, technology, and end-user.

The market, based on product, has been divided into instruments and accessories. Instruments are further sub-segmented into rotary microtomes, cryostat microtomes, vibrating microtomes, and others. Instruments are expected to hold the largest share, due to the commercial availability of these systems and their high adoption rate due to ease of handling.

In terms of application, the global microtome market has been segmented into disease diagnosis and medical research. Disease diagnosis takes up the largest share due to the increasing number of tissue examinations in research laboratories and hospitals owing to rising awareness about the benefits of early diagnosis of diseases like cancer.

In terms of technology, the global microtome market has been segmented into manual, semi-automated microtomes, and fully automated microtomes. The fully automated segment held the majority share due to rising demand for technologically advanced products and its ability to show the highest precision in section thickness. Additionally, fully automated microtomes do not require tedious manual adjustments.

In terms of end-user, the global microtome market has been segmented into hospital laboratories and clinical laboratories. Hospital laboratories take up the largest share. The positive growth of hospitals is attributed to factors such as a high volume of routine tissue examinations performed in hospital-based laboratories across the globe and growing patient population.

Key Players

Some of the key players in the Global Microtome Market are Amos Scientific Pty Ltd (Australia), Danaher (US), Diapath S.p.A. (Italy), Histo-Line Laboratories (Italy), Jinhua YIDI Medical Appliance Co., Ltd (China), MEDITE GmbH (Germany), Boeckeler Instruments, Inc. (US), Sakura Finetek (Japan), SLEE Medical GmbH (Germany), and Thermo Fisher Scientific (US)

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/microtome-market-8568

About Us:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

Menopause Treatment Market Growth Analysis, Industry Trends, And Forecast By 2027

Market Highlights

Global Menopause Treatment Market is expected to have a market value of USD 15,456.3 Million by 2027. Menopause causes uncomfortable symptoms, such as hot flashes, vaginal dryness, and weight gain and menopause treatments such as hormonal and non-hormonal treatments help to relieve these symptoms. Over the years, major market players in the menopause treatment are focusing on various growth strategies such as product launches, product advancements and expansions to cater to the growing needs for patients seeking treatment for menopause symptoms. For instance, in April 2019, Otsuka Pharmaceutical launched EQUELLE, a non-prescription, non-hormonal supplement to alleviate the frequency of hot flashes and muscle aches associated with menopause in the US. Such strategies push the demand for branded as well as generic menopausal drugs, thus promising huge growth for the industry.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/4579

Segment Analysis

The global menopause treatment market is segmented based on treatment and distribution channel.

The global menopause treatment market based on the treatment has been segmented into hormonal treatment and non-hormonal treatment. The hormonal treatment segment is further segmented into estrogen, progesterone, and combination. The non-hormonal treatment is further segmented into anti-depressants and others.

Based on distribution channel, the menopause treatment market is segmented into hospital pharmacies, retail pharmacies, and online stores.

Regional Analysis

The global menopause treatment market, based on region, has been divided into the Americas, Europe, Asia-Pacific, and Middle East & Africa.

The Americas has been segmented into North America and Latin America, with the North America market further divided into the US and Canada. The Americas led the market and accounted for the largest share in 2019 owing to the increasing product approvals and high uptake of new technology. For instance, in July 2017, AMAG Pharmaceuticals, Inc. (US) launched Intrarosa (prasterone) for the treatment of moderate to severe dyspareunia a symptom of vulvar and vaginal atrophy (VVA), due to menopause. Thus, such strategies employed by major players aid in the increased growth rate for the Americas menopause treatment industry.

The European menopause treatment market has been further segmented into Western Europe and Eastern Europe. The Western Europe menopause treatment market has further been classified into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. Europe follows the Americas in the global menopause treatment market. The increasing inclination of companies towards female technology (femtech) is boosting the growth of the menopause treatment market in European countries. Many digital health start-ups have identified this opportunity and are offering B2C digital health tools, such as mobile apps, to guide menopausal women through this phase with lifestyle intervention tips and online telehealth consultations. As a result, the region is expected to show significant growth in the menopause treatment market.

The menopause treatment market in Asia-Pacific has been segmented into China, India, Japan, South Korea, Australia, and the rest of Asia-Pacific. Asia-Pacific is expected to register the highest growth rate over the forecast period from 2020 to 2027. This is owing to the growing penetration of the women’s health sector, increasing awareness about the betterment of the women’s health, and the growing number of educational campaigns related to the benefits of hormone replacement therapy in China, Japan, India, and Australia.

The Middle East & Africa menopause treatment market is segmented Saudi Arabia, the United Arab Emirates (UAE), Oman, Kuwait, Qatar, and the rest of the Middle East & Africa. The negative connotation of menopause has resulted in a negative attitude towards menopause in premenopausal women. However, with the increasing awareness created by private companies, the scenario is expected to change in the next ten years.

Key Players

MRFR recognizes the following companies as the Key Players in the Global Menopause Treatment Market— Novo Nordisk A/S (Denmark), Pfizer Inc. (US), Allergan (Ireland), Eli Lily and Company (US), Emcure Pharmaceuticals Ltd (India), Novartis AG (Switzerland), Cipla Inc. (India), Teva Pharmaceuticals (Israel), Merck & Co., Inc. (US), Abbott Laboratories (US).

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/menopause-treatment-market-4579

About Us:

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com